查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
动物感染疾病诊断市场 - 全球和区域分析：按技术、产品、动物类型、感染类型、最终用户和区域 - 分析和预测（2025-2035 年）
市场调查报告书
商品编码
1814815

动物感染疾病诊断市场 - 全球和区域分析：按技术、产品、动物类型、感染类型、最终用户和区域 - 分析和预测（2025-2035 年）

Veterinary Infectious Disease Diagnostics Market - A Global and Regional Analysis: Focus on Technology, Product, Animal Type, Infection Type, End user, Country, and Region - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 120 Pages | 商品交期: 1-5个工作天内

价格

全球动物感染疾病诊断市场 - 分析与预测（2025-2035）

兽医感染疾病诊断是指透过各种实验室测试和诊断技术来识别和检测动物感染疾病。

这些疾病不仅影响犬、猫、马等伴侣动物，也影响牛、家禽和猪等牲畜。早期准确检测对于控制疫情、保障动物福利、防止通用感染疾病从动物传播给人类至关重要。

诊断方法包括分子技术，例如PCR和次世代定序，可在基因层面识别病原体；免疫诊断测试，例如ELISA，可检测抗体和抗原；以及微生物培养，可分离细菌和病毒。快速诊断测试也常用于现场快速识别疾病。总体而言，兽医感染疾病诊断在疾病预防、动物健康管理和公共卫生保护中发挥着至关重要的作用。因此，它们是兽医、农民和宠物饲主就治疗和护理做出明智决策的重要工具。

兽医感染疾病诊断的主要优势之一是能够早期发现并准确识别动物感染疾病。早期识别至关重要，因为它可以及时治疗，降低疾病严重程度，并防止其传播给其他动物，甚至在通用感染疾病，防止其传播给人类。准确的诊断使兽医能够识别导致感染疾病的特定病原体，从而进行针对性治疗，而不是使用广谱抗生素或无效药物。这不仅可以提高治疗效果，还可以透过避免不必要的抗生素使用来降低抗生素抗药性的风险。

此外，及时检测有助于快速识别疫情，最大限度地减少畜牧业的经济损失，并确保宠物和其他动物的健康和福利，从而控制和预防疾病。总而言之，兽医感染疾病诊断可以改善动物健康，增强动物福利，并提高公共卫生安全。

动物感染疾病诊断市场的主要驱动力之一是通用感染疾病的盛行率不断上升，感染疾病疾病由动物传播通用人类，对公共健康构成重大风险，促使兽医加强监测和诊断工作。

对这些风险的认识不断提高，推动了对快速且准确的诊断工具的需求，以检测伴侣动物和牲畜的感染。这一趋势在北美等地区尤其明显，通用感染疾病发生率的上升推动了分子诊断、就地检验和次世代定序等先进诊断技术的采用。

儘管兽医感染疾病诊断市场正在成长，但仍存在一些挑战。其中一个主要挑战是诊断测试和先进技术的高成本。虽然分子诊断、PCR检测和次世代定序能够提供高度准确的结果，但它们需要在设备、试剂和培训方面投入大量资金。这种高成本对许多兽医诊所，尤其是资源匮乏地区或小型诊所来说，可能是一个障碍。此外，这些技术的复杂性需要熟练的专业人员，这进一步增加了实施成本。

另一个挑战是不同地区缺乏标准化的法规和统一的诊断方法。不一致的监管标准可能导致诊断工具的品质和可用性存在差异，从而可能影响其广泛应用。此外，需要加强全球协调，以确保诊断工具符合国际标准，尤其是在通用感染疾病易发地区。

此外，由于抵制变革以及缺乏对先进诊断能力的了解等因素，一些市场对新技术的采用缓慢，这也导致了市场成长缓慢。克服这些挑战对于确保公平获得优质诊断服务以及改善全球动物健康管理至关重要。

全球动物感染疾病诊断市场竞争激烈，主要由 IDEXX Laboratories, Inc.、Zoetis、Thermo Fisher Scientific Inc.、Virbac、bioMerieux SA、Heska Corporation、Neogen Corporation、Randox Laboratories Ltd.、Agrolabo SpA、Indical Bioscience GmbH (QCheiagen NVie) 和主要推动参与者。

这些公司专注于开发先进的诊断解决方案，以满足日益增长的对动物感染疾病准确及时检测的需求。其多样化的产品系列包括分子诊断、免疫诊断和适用于各种兽医应用的快速检测套组。动物健康管理需求的不断增长、人们对通用感染疾病的认识不断提高以及诊断技术的进步，正在刺激市场竞争和创新，进一步提高兽医诊断的可用性和有效性。

动物感染疾病诊断市场细分

细分一：依技术

  • 免疫诊断剂
    • 横向流动化验
    • ERISA测试
    • 其他的
  • 分子诊断
  • 聚合酵素链锁反应（PCR）检测
    • 微阵列
    • 其他的
  • 其他技术

细分 2：依产品

  • 耗材、试剂和套件
  • 设备/器具

细分3：依动物类型

  • 伴侣动物
    • 狗
    • 猫
    • 马
    • 其他的
  • 食用动物
    • 牛
    • 猪
    • 家禽
    • 其他的

细分 4：按感染类型

  • 伴侣动物
    • 病毒感染
    • 细菌感染
    • 寄生虫感染
    • 其他的
  • 食用动物
    • 病毒感染疾病
    • 细菌感染疾病
    • 寄生虫感染疾病
    • 其他的

第 5 部分：按最终用户

  • 兽医参考实验室
  • 兽医医院和诊所
  • 即时诊断/院内检测
  • 兽医研究机构和大学

细分6：按地区

  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

全球动物感染疾病诊断市场最重要的新兴趋势之一是将人工智慧 (AI) 和机器学习 (ML) 技术融入诊断平台。这些进步正在提高诊断的准确性、速度和效率，尤其是在照护现场。

人工智慧和机器学习演算法能够分析图像和基因组资讯等复杂资料集，从而更有效地识别病原体并预测疾病爆发。例如，人工智慧诊断工具可以帮助兽医及早发现伴侣动物和牲畜的感染疾病，从而及时介入并改善动物健康。

人工智慧和机器学习的采用也将促进可在现场使用的快速诊断测试的开发，减少对集中实验室的依赖并实现更快的决策，这一趋势对于兽医诊断基础设施有限的地区尤其有利。

总体而言，人工智慧和机器学习融入兽医诊断正在改变动物保健的格局，使疾病检测更加便捷和高效，并支持更好地管理动物感染疾病。

目录

执行摘要

第一章全球动物感染疾病诊断市场：产业展望

  • 介绍
  • 市场趋势
  • 法律规范
  • 专利分析
  • 案例研究
  • 产品基准
  • 市场动态

2. 全球动物感染疾病诊断市场（按技术），2024-2035

  • 免疫诊断
  • 分子诊断
  • 聚合酵素链锁反应（PCR）检测
  • 其他的

3. 全球动物感染疾病诊断市场（依产品），2024-2035

  • 耗材、试剂和套件
  • 设备和仪器

4. 2024-2035 年全球动物感染疾病诊断市场（按动物类型）

  • 伴侣动物
  • 食用动物

5. 全球动物感染疾病诊断市场（依感染疾病类型），2024-2035

  • 伴侣动物
  • 食用动物

6. 2024-2035 年全球动物感染疾病诊断市场（依最终使用者划分）

  • 兽医参考实验室
  • 兽医医院和诊所
  • 照护现场/内部侦测
  • 兽医研究机构和大学

7. 2023-2035年全球动物感染疾病诊断市场（按地区）

  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

8. 全球动物感染疾病诊断市场：竞争格局与公司简介

  • 关键策略和发展
  • 公司简介
    • IDEXX Laboratories, Inc.
    • Zoetis
    • Thermo Fisher Scientific Inc.
    • Virbac
    • bioMerieux SA
    • Heska Corporation
    • Neogen Corporation
    • Randox Laboratories Ltd.
    • Agrolabo SpA
    • Indical Bioscience GmbH (Qiagen NV)
    • BioChek (bioMerieux)
    • Antech Diagnostics, Inc.
    • IDVet
    • Bio-Rad Laboratories, Inc
    • Shenzhen Bioeasy Biotechnology Co., Ltd.

第九章调查方法

Product Code: BHM3264SA

Global Veterinary Infectious Disease Diagnostics Market, Analysis and Forecast: 2025-2035

Veterinary infectious disease diagnostics refers to the identification and detection of infectious diseases in animals through various laboratory tests and diagnostic techniques. These diseases can affect both companion animals like dogs, cats, and horses, as well as livestock such as cattle, poultry, and swine. Early and accurate detection is crucial for controlling outbreaks, ensuring animal welfare, and preventing the spread of zoonotic diseases those that can be transmitted from animals to humans.

Diagnostic methods include molecular techniques like PCR and Next-Generation Sequencing for identifying pathogens at the genetic level, immunodiagnostic tests such as ELISA to detect antibodies or antigens, and microbiological cultures to isolate bacteria or viruses. Rapid diagnostic tests are also commonly used in field settings for quick disease identification. Overall, veterinary infectious disease diagnostics plays a vital role in disease prevention, animal health management, and safeguarding public health. As such, it is an essential tool for veterinarians, farmers, and pet owners to make informed decisions regarding treatment and care.

One of the primary advantages of veterinary infectious disease diagnostics is its ability to enable early detection and precise identification of infectious diseases in animals. Early identification is crucial because it allows for prompt treatment, reducing the severity of the disease and preventing its spread to other animals or even to humans in the case of zoonotic diseases. Accurate diagnostics help veterinarians determine the specific pathogen responsible for an infection, which enables targeted treatments rather than broad-spectrum antibiotics or ineffective medications. This not only improves the effectiveness of treatments but also reduces the risk of antimicrobial resistance by avoiding unnecessary use of antibiotics.

Additionally, timely detection helps in disease management and prevention by identifying outbreaks quickly, thereby minimizing economic losses in livestock industries and ensuring the health and welfare of pets and other animals. Overall, veterinary infectious disease diagnostics supports better animal health outcomes, improves animal welfare, and enhances public health safety.

One of the key drivers of the veterinary infectious disease diagnostics market is the rising prevalence of zoonotic diseases. Zoonotic diseases those transmitted from animals to humans pose significant public health risks and have prompted increased surveillance and diagnostic efforts in veterinary medicine.

The growing awareness of these risks has led to heightened demand for rapid and accurate diagnostic tools to detect infections in both companion animals and livestock. This trend is particularly evident in regions like North America, where the increasing incidence of zoonotic diseases is driving the adoption of advanced diagnostic technologies such as molecular diagnostics, point-of-care testing, and next-generation sequencing.

Despite the growth of the veterinary infectious disease diagnostics market, several challenges persist. One of the primary challenges is the high cost of diagnostic tests and advanced technologies. While molecular diagnostics, PCR assays, and next-generation sequencing provide highly accurate results, they require significant investment in equipment, reagents, and training. This high cost can be a barrier for many veterinary clinics, especially in low-resource settings or for smaller practices. Additionally, the complexity of these technologies demands skilled professionals, further increasing the cost of implementation.

Another challenge is the lack of standardized regulations and uniformity in diagnostic practices across different regions. Inconsistent regulatory standards can lead to variations in the quality and availability of diagnostic tools, affecting their widespread adoption. There is also a need for more global coordination to ensure that diagnostic tools meet international standards, particularly in areas prone to zoonotic outbreaks.

Furthermore, the slow adoption of new technologies in certain markets due to factors such as resistance to change and lack of awareness about advanced diagnostic capabilities contributes to slower market growth in some regions. Overcoming these challenges is crucial for ensuring equitable access to high-quality diagnostics and improving animal health management worldwide.

The global Veterinary Infectious Disease Diagnostics market is highly competitive, with major players such as IDEXX Laboratories, Inc., Zoetis, Thermo Fisher Scientific Inc., Virbac, bioMerieux S.A., Heska Corporation, Neogen Corporation, Randox Laboratories Ltd., Agrolabo S.p.A., Indical Bioscience GmbH (Qiagen N.V.), and BioChek (bioMerieux) leading the way.

These companies are focused on developing advanced diagnostic solutions to address the growing need for accurate and timely detection of infectious diseases in animals. Their diverse product portfolios include molecular diagnostics, immunodiagnostics, and rapid testing kits, catering to a wide range of veterinary applications. The increasing demand for animal health management, rising awareness of zoonotic diseases, and advancements in diagnostic technology are fueling competition and innovation in the market, further enhancing the availability and effectiveness of veterinary diagnostics.

Veterinary Infectious Disease Diagnostics Market Segmentation:

Segmentation 1: by Technology

  • Immunodiagnostics
    • Lateral Flow Assays
    • Elisa Tests
    • Other Immunodiagnostic Products
  • Molecular Diagnostics
  • Polymerase Chain Reaction (PCR) Tests
    • Microarrays
    • Other Molecular Diagnostic Products
  • Other Technologies

Segmentation 2: by Product

  • Consumables, Reagents & Kits
  • Equipment & Instruments

Segmentation 3: by Animal Type

  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Other Companion Animals
  • Food-Producing Animals
    • Cattle
    • Swine
    • Poultry
    • Other food-producing animals

Segmentation 4: by Infection Type

  • Companion Animals
    • Viral infections
    • Bacterial infections
    • Parasitic infections
    • Other infections
  • Food-Producing Animals
    • Viral infections
    • Bacterial infections
    • Parasitic infections
    • Other infections

Segmentation 5: by End User

  • Veterinary Reference Laboratories
  • Veterinary Hospitals & Clinics
  • Point-Of-Care/ In-House Testing
  • Veterinary Research Institutes & Universities

Segmentation 6: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

One of the most significant emerging trends in the global veterinary infectious disease diagnostics market is the integration of artificial intelligence (AI) and machine learning (ML) technologies into diagnostic platforms. These advancements are enhancing the accuracy, speed, and efficiency of diagnostics, particularly in point-of-care settings.

AI and ML algorithms enable the analysis of complex data sets, such as imaging and genomic information, to identify pathogens and predict disease outbreaks more effectively. For instance, AI-powered diagnostic tools can assist veterinarians in detecting infections in companion animals and livestock at earlier stages, leading to timely interventions and improved animal health outcomes.

The adoption of AI and ML is also facilitating the development of rapid diagnostic tests that can be used in field settings, reducing the reliance on centralized laboratories and enabling quicker decision-making. This trend is particularly beneficial in regions with limited access to veterinary diagnostic infrastructure.

Overall, the incorporation of AI and ML into veterinary diagnostics is transforming the landscape of animal healthcare, making disease detection more accessible and efficient, and supporting better management of infectious diseases in animals.

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

1. Global Veterinary Infectious Disease Diagnostics Market: Industry Outlook

  • 1.1 Introduction
  • 1.2 Market Trends
  • 1.3 Regulatory Framework
  • 1.4 Patent Analysis
  • 1.5 Case Studies
  • 1.6 Product Benchmarking
  • 1.7 Market Dynamics
    • 1.7.1 Impact Analysis
    • 1.7.2 Market Drivers
    • 1.7.3 Market Challenges
    • 1.7.4 Market Opportunities

2. Global Veterinary Infectious Disease Diagnostics Market (by Technology), ($Billion), 2024-2035

  • 2.1 Immunodiagnostics
    • 2.1.1 Lateral Flow Assays
    • 2.1.2 Elisa Tests
    • 2.1.3 Other Immunodiagnostic Products
  • 2.2 Molecular Diagnostics
  • 2.3 Polymerase Chain Reaction (PCR) Tests
    • 2.3.1 Microarrays
    • 2.3.2 Other Molecular Diagnostic Products
  • 2.4 Other Technologies

3. Global Veterinary Infectious Disease Diagnostics Market (by Product), ($Billion), 2024-2035

  • 3.1 Consumables, Reagents & Kits
  • 3.2 Equipment & Instruments

4. Global Veterinary Infectious Disease Diagnostics Market (by Animal Type), ($Billion), 2024-2035

  • 4.1 Companion Animals
    • 4.1.1 Dogs
    • 4.1.2 Cats
    • 4.1.3 Horses
    • 4.1.4 Other Companion Animals
  • 4.2 Food-Producing Animals
    • 4.2.1 Cattle
    • 4.2.2 Swine
    • 4.2.3 Poultry
    • 4.2.4 Other food-producing animals

5. Global Veterinary Infectious Disease Diagnostics Market (by Infection Type), ($Billion), 2024-2035

  • 5.1 Companion Animals
    • 5.1.1 Viral infections
    • 5.1.2 Bacterial infections
    • 5.1.3 Parasitic infections
    • 5.1.4 Other infections
  • 5.2 Food-Producing Animals
    • 5.2.1 Viral infections
    • 5.2.2 Bacterial infections
    • 5.2.3 Parasitic infections
    • 5.2.4 Other infections

6. Global Veterinary Infectious Disease Diagnostics Market (by End User), ($Billion), 2024-2035

  • 6.1 Veterinary Reference Laboratories
  • 6.2 Veterinary Hospitals & Clinics
  • 6.3 Point-Of-Care/ In-House Testing
  • 6.4 Veterinary Research Institutes & Universities

7. Global Veterinary Infectious Disease Diagnostics Market (by Region), ($Billion), 2023-2035

  • 7.1 North America
    • 7.1.1 Key Findings
    • 7.1.2 Market Dynamics
    • 7.1.3 Market Sizing and Forecast
      • 7.1.3.1 North America Veterinary Infectious Disease Diagnostics Market, by Country
        • 7.1.3.1.1 U.S.
        • 7.1.3.1.2 Canada
  • 7.2 Europe
    • 7.2.1 Key Findings
    • 7.2.2 Market Dynamics
    • 7.2.3 Market Sizing and Forecast
      • 7.2.3.1 Europe Veterinary Infectious Disease Diagnostics Market, by Country
        • 7.2.3.1.1 Germany
        • 7.2.3.1.2 U.K.
        • 7.2.3.1.3 France
        • 7.2.3.1.4 Italy
        • 7.2.3.1.5 Spain
        • 7.2.3.1.6 Rest of the Europe
  • 7.3 Asia Pacific
    • 7.3.1 Key Findings
    • 7.3.2 Market Dynamics
    • 7.3.3 Market Sizing and Forecast
      • 7.3.3.1 Asia Pacific Veterinary Infectious Disease Diagnostics Market, by Country
        • 7.3.3.1.1 China
        • 7.3.3.1.2 Japan
        • 7.3.3.1.3 India
        • 7.3.3.1.4 Australia
        • 7.3.3.1.5 Rest of Asia Pacific
  • 7.4 Rest of the World
    • 7.4.1 Key Findings
    • 7.4.2 Market Dynamics
    • 7.4.3 Market Sizing and Forecast

8. Global Veterinary Infectious Disease Diagnostics Market: Competitive Landscape and Company Profiles

  • 8.1 Key Strategies and Development
    • 8.1.1 Mergers and Acquisitions
    • 8.1.2 Synergistic Activities
    • 8.1.3 Business Expansions and Funding
    • 8.1.4 Product Launches and Approvals
    • 8.1.5 Other Activities
  • 8.2 Company Profiles
    • 8.2.1 IDEXX Laboratories, Inc.
      • 8.2.1.1 Overview
      • 8.2.1.2 Top Products / Product Portfolio
      • 8.2.1.3 Top Competitors
      • 8.2.1.4 Target Customers/End-Users
      • 8.2.1.5 Key Personnel
      • 8.2.1.6 Analyst View
    • 8.2.2 Zoetis
      • 8.2.2.1 Overview
      • 8.2.2.2 Top Products / Product Portfolio
      • 8.2.2.3 Top Competitors
      • 8.2.2.4 Target Customers/End-Users
      • 8.2.2.5 Key Personnel
      • 8.2.2.6 Analyst View
    • 8.2.3 Thermo Fisher Scientific Inc.
      • 8.2.3.1 Overview
      • 8.2.3.2 Top Products / Product Portfolio
      • 8.2.3.3 Top Competitors
      • 8.2.3.4 Target Customers/End-Users
      • 8.2.3.5 Key Personnel
      • 8.2.3.6 Analyst View
    • 8.2.4 Virbac
      • 8.2.4.1 Overview
      • 8.2.4.2 Top Products / Product Portfolio
      • 8.2.4.3 Top Competitors
      • 8.2.4.4 Target Customers/End-Users
      • 8.2.4.5 Key Personnel
      • 8.2.4.6 Analyst View
    • 8.2.5 bioMerieux S.A.
      • 8.2.5.1 Overview
      • 8.2.5.2 Top Products / Product Portfolio
      • 8.2.5.3 Top Competitors
      • 8.2.5.4 Target Customers/End-Users
      • 8.2.5.5 Key Personnel
      • 8.2.5.6 Analyst View
    • 8.2.6 Heska Corporation
      • 8.2.6.1 Overview
      • 8.2.6.2 Top Products / Product Portfolio
      • 8.2.6.3 Top Competitors
      • 8.2.6.4 Target Customers/End-Users
      • 8.2.6.5 Key Personnel
      • 8.2.6.6 Analyst View
    • 8.2.7 Neogen Corporation
      • 8.2.7.1 Overview
      • 8.2.7.2 Top Products / Product Portfolio
      • 8.2.7.3 Top Competitors
      • 8.2.7.4 Target Customers/End-Users
      • 8.2.7.5 Key Personnel
      • 8.2.7.6 Analyst View
    • 8.2.8 Randox Laboratories Ltd.
      • 8.2.8.1 Overview
      • 8.2.8.2 Top Products / Product Portfolio
      • 8.2.8.3 Top Competitors
      • 8.2.8.4 Target Customers/End-Users
      • 8.2.8.5 Key Personnel
      • 8.2.8.6 Analyst View
    • 8.2.9 Agrolabo S.p.A.
      • 8.2.9.1 Overview
      • 8.2.9.2 Top Products / Product Portfolio
      • 8.2.9.3 Top Competitors
      • 8.2.9.4 Target Customers/End-Users
      • 8.2.9.5 Key Personnel
      • 8.2.9.6 Analyst View
    • 8.2.10 Indical Bioscience GmbH (Qiagen N.V.)
      • 8.2.10.1 Overview
      • 8.2.10.2 Top Products / Product Portfolio
      • 8.2.10.3 Top Competitors
      • 8.2.10.4 Target Customers/End-Users
      • 8.2.10.5 Key Personnel
      • 8.2.10.6 Analyst View
    • 8.2.11 BioChek (bioMerieux)
      • 8.2.11.1 Overview
      • 8.2.11.2 Top Products / Product Portfolio
      • 8.2.11.3 Top Competitors
      • 8.2.11.4 Target Customers/End-Users
      • 8.2.11.5 Key Personnel
      • 8.2.11.6 Analyst View
    • 8.2.12 Antech Diagnostics, Inc.
      • 8.2.12.1 Overview
      • 8.2.12.2 Top Products / Product Portfolio
      • 8.2.12.3 Top Competitors
      • 8.2.12.4 Target Customers/End-Users
      • 8.2.12.5 Key Personnel
      • 8.2.12.6 Analyst View
    • 8.2.13 IDVet
      • 8.2.13.1 Overview
      • 8.2.13.2 Top Products / Product Portfolio
      • 8.2.13.3 Top Competitors
      • 8.2.13.4 Target Customers/End-Users
      • 8.2.13.5 Key Personnel
      • 8.2.13.6 Analyst View
    • 8.2.14 Bio-Rad Laboratories, Inc
      • 8.2.14.1 Overview
      • 8.2.14.2 Top Products / Product Portfolio
      • 8.2.14.3 Top Competitors
      • 8.2.14.4 Target Customers/End-Users
      • 8.2.14.5 Key Personnel
      • 8.2.14.6 Analyst View
    • 8.2.15 Shenzhen Bioeasy Biotechnology Co., Ltd.
      • 8.2.15.1 Overview
      • 8.2.15.2 Top Products / Product Portfolio
      • 8.2.15.3 Top Competitors
      • 8.2.15.4 Target Customers/End-Users
      • 8.2.15.5 Key Personnel
      • 8.2.15.6 Analyst View

9. Research Methodology

List of Figures

  • Figure: Global Veterinary Infectious Disease Diagnostics Market (by Technology), $Billion, 2024 and 2035
  • Figure: Global Veterinary Infectious Disease Diagnostics Market (by Product), $Billion, 2024 and 2035
  • Figure: Global Veterinary Infectious Disease Diagnostics Market (by Animal Type), $Billion, 2024 and 2035
  • Figure: Global Veterinary Infectious Disease Diagnostics Market (by Infection Type), $Billion, 2024 and 2035
  • Figure: Global Veterinary Infectious Disease Diagnostics Market (by End User), $Billion, 2024 and 2035
  • Figure: Global Veterinary Infectious Disease Diagnostics Market (by Region), $Billion, 2024 and 2035
  • Figure: Global Veterinary Infectious Disease Diagnostics Market Key Trends, Analysis

List of Tables

  • Table: Global Veterinary Infectious Disease Diagnostics Market Dynamics, Impact Analysis
  • Table: Global Veterinary Infectious Disease Diagnostics Market (by Region), $Billion, 2024-2035